Evidence map›Paper›PMID 32876195›Full record

ArticleArquivos brasileiros de cardiologia2020

Pharmacological Treatment of Hypertension: From the Golden Trio to the Octet.

Audes Diógenes Magalhães Feitosa, Marco Mota-Gomes, Oswaldo Passarelli Júnior, Weimar Kunz Sebba Barroso, Roberto Dischinger Miranda, Eduardo Costa Duarte Barbosa, Andrea A Brandão, Wilson Nadruz

Abstract read
In one paragraph

Article in Arquivos brasileiros de cardiologia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Brazilian Guidelines of Hypertension - 2025.Arquivos brasileiros de cardiologia · 2025
    Article
  2. Article
  3. Brazilian Guidelines of Hypertension - 2020.Arquivos brasileiros de cardiologia · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Audes Diógenes Magalhães FeitosaUnidade de Hipertensão e Cardiologia Preventiva, PROCAPE, Universidade de Pernambuco, Recife, PE - Brasil.ORCID 0000-0002-9983-4720
Marco Mota-GomesCentro Universitário CESMAC, Maceió, AL - Brasil.ORCID 0000-0002-6652-1533
Oswaldo Passarelli JúniorInstituto Dante Pazzanese de Cardiologia,São Paulo, SP - Brasil.
Weimar Kunz Sebba BarrosoUniversidade Federal de Goiás - Liga de Hipertensão, Goiânia, GO - Brasil.ORCID 0000-0002-1265-1930
Roberto Dischinger MirandaUniversidade Federal de São Paulo - Escola Paulista de Medicina, São Paulo, SP - Brasil.ORCID 0000-0002-1582-7268
Eduardo Costa Duarte BarbosaLiga de Hipertensão de Porto Alegre, Porto Alegre, RS - Brasil.ORCID 0000-0002-4361-936X
Andrea A BrandãoUniversidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ - Brasil.ORCID 0000-0002-7040-396X
Wilson NadruzUniversidade Estadual de Campinas, Campinas, SP - Brasil.ORCID 0000-0002-0003-5102

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antihypertensive AgentsHypertensionHumansAntihypertensive Agents

Identifiers

PMID32876195
PMCPMC8384273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.